TELA Bio Launches $40 Million Public Offering of Common Stock
TELA Bio Initiates Exciting Public Offering TELA Bio, Inc. has embarked on a pivotal journey in the medical technology industry by announcing a public offering of its common stock and pre-funded warrants. This offering is a significant move aimed at raising $40 million for various corporate purposes that align with TELA's commitment to innovating soft-tissue...
Continue Reading